Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schroeder, Heidi K
DOTS-AD, NCT04245748: Determining Optimal Treatment Sequences in Anxious Depression	Recruiting	4	84	US	Escitalopram, Lexapro, Duloxetine, Cymbalta	University of Cincinnati	Anxious Depression, Depression	07/25	12/25
EV-SoPRANO, NCT04221997: Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.	Recruiting	4	150	US	sertraline, Zoloft	University of Cincinnati, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Anxiety Disorders	09/26	09/26
PrEcISE, NCT04623099: Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy	Recruiting	4	132	US	Escitalopram, Lexapro	University of Cincinnati, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Anxiety	06/26	12/26
PCAY, NCT04598230: Partners in Caring for Anxious Youth	Recruiting	3	468	US	Cognitive Behavioral Therapy (CBT), CBT, psychotherapy, Combination therapy (COMB), SSRI plus CBT, COMB	Ann & Robert H Lurie Children's Hospital of Chicago, University of Cincinnati, University of California, Los Angeles	Anxiety, Separation, Anxiety, Generalized, Anxiety, Social	12/24	04/25
Panorama, NCT06809595: A Phase 3 Trial of MM120 for Generalized Anxiety Disorder	Recruiting	3	250	US	Placebo, MM120 (LSD D-Tartrate)	Mind Medicine, Inc.	Generalized Anxiety Disorder	11/26	05/27